WFM
CBST

Wilmington Funds Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Wilmington Funds Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$515K Buy
7,372
+1,700
+30% +$116K 0.05% 351
2014
Q1 		$415K Sell
5,672
-1,789
-24% -$133K 0.05% 420
2013
Q4 		$514K Sell
7,461
-3,489
-32% -$226K 0.05% 381
2013
Q3 		$696K Buy
10,950
+158
+1% +$9.55K 0.07% 296
2013
Q2 		$521K Buy
+10,792
New +$530K 0.05% 361

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wilmington Funds Management's CBST Position: Q2 2014 in Review

Wilmington Funds Management increased its CUBIST PHARMACEUTICALS INC (CBST) stake by 30% in Q2 2014, buying an estimated $116K and bringing the position to 7,372 shares worth $515K. The position accounts for 0.05% of the portfolio, ranked #351.

Wilmington Funds Management first reported a position in CBST in Q2 2013 and has held it in 5 quarters since. The position peaked at $696K in Q3 2013. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Wilmington Funds Management held 7,372 shares of CUBIST PHARMACEUTICALS INC worth $515K as of Q2 2014.
  • Wilmington Funds Management bought 1,700 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $116K.
  • CUBIST PHARMACEUTICALS INC made up 0.05% of Wilmington Funds Management's portfolio in Q2 2014, its #351 holding.
  • Wilmington Funds Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Funds Management's CUBIST PHARMACEUTICALS INC position peaked at $696K in Q3 2013.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.